Kyna Conn

Post-doc @MonashBDI // @QldBrainInst Alumna /
Researching the neurobiology of 🍄 psychedelics & anorexia nervosa #FoldiLab

[Kyna Conn @KynaConn]

Proud to have co-led this important study w/ @LauraKMilton and to finally bring to fruition the pioneering vision of @ClaireFoldi in @molpsychiatry . It has been an honour to work with #psilocybin 🍄 in Australia @MonashBDI

https://t.co/mGe5yy8KBv

[Claire Foldi @ClaireFoldi]

2) Preprint from the final project led by @KynaConn during her postdoc on how dopamine drives improved reversal learning after psilocybin 🍄‍🟫

https://t.co/DrMWnOLPGW

[Biological Psychiatry Australia @biolpsychaust]

The amazing science continues with our second session for the day at #BPA2025! Congratulations to @KynaConn, @hkatemacpherson and Xavier Maddern on being awarded the highest ranked abstracts for this years meeting.

[Kyna Conn @KynaConn]

In our exciting new study led by @SezSaysScience and @ClaireFoldi, cachexia in a pancreatic cancer mouse model impaired reversal learning without elevating anxiety, suggesting sickness-induced reward devaluation can uniquely disrupt cognitive flexibility
https://t.co/cmlaZo8ub5

[Kyna Conn @KynaConn]

Awesome to see Shedia present her exciting work on PSI effects on social behaviour at this year's @IBNSconnect!! Come check it out 🍄🍄

[Sheidita @Sheida_Shadani]

Come to my poster #131 @IBNSconnect 🧠 🍄‍🟫 ✨

[Claire Foldi @ClaireFoldi]

Writing this was like any other act of love - awkward at the start, frustrating at times, but something to be proud of. Very grateful to @DrK_Griffiths for agreeing to take on this challenge with me @NatRevNeurosci

https://t.co/6dkuocGelL

[Zane Andrews @zane_andrews1]

We created a python package for photometry post-hoc analysis using bootstrapping confidence Intervals

No more AUC or time bins analysis! Ever

Follow our simple step by step instructions.

Thanks....
@DrReal82 @ClaireFoldi @philURDB @Stark_BrainSci

https://t.co/I9yLlqwFIb

[Claire Foldi @ClaireFoldi]

are my behav neuro peeps still here? I posted the fabulous new work from the lab, led by PhD student @KaixinCHuang over on the other place last night and got crickets... check it out!!
https://t.co/Da6vbq1WIT

[Kyna Conn @KynaConn]

My brilliant friend @Joeybenetatos from post-grad is joining the @MonashBDI seminar series today to present the cutting-edge techniques he uses to better understand psychedelic mechanisms of action. Please come along and support this very talented ECR!

[Claire Foldi @ClaireFoldi]

Forgot to post in real time but THE @KynaConn crushed her poster presentation @ecnptweets in Milan this week. Figured out how to include a QR code and everything #genius #ECNP2024

[Sheidita @Sheida_Shadani]

I’m so excited to share my first paper on “Potential Differences in Psychedelic Actions Based on Biological Sex” 🍄‍🟫✨

I am deeply grateful to my incredible supervisor @ClaireFoldi for her support and guidance throughout this process 💙

https://t.co/l3xlDlkPCE

[Kyna Conn @KynaConn]

None of this would have been possible without the indispensable contributions from members of the #FoldiLab and co-authors: @KaixinCHuang @hermanymv @janikaruuska @BrianOldfield_1 as well as non-X users Moyra, Erika & Jih ♥️

[Kyna Conn @KynaConn]

Proud to have co-led this important study w/ @LauraKMilton and to finally bring to fruition the pioneering vision of @ClaireFoldi in @molpsychiatry . It has been an honour to work with #psilocybin 🍄 in Australia @MonashBDI

https://t.co/mGe5yy8KBv

[Kyna Conn @KynaConn]

We show that psilocybin improves body weight maintenance in activity-based anorexia, enhances cognitive flexibility in a reversal learning task, and causes transient changes in inhibitory output from the prefrontal cortex via 5-HT1A and 5-HT2A mechanisms

[Claire Foldi @ClaireFoldi]

Join us in Lorne in November 🌞🏖️ and give our X account a follow @BDI_MDOP - we had a technical issue last year and lost all our lovely followers 😥

[Kyna Conn @KynaConn]

@synaptic_soph @ClaireFoldi Very cool!!

[Claire Foldi @ClaireFoldi]

They say to “write what you know” but ⁦@feliciamreed1 & I broke with convention to write about what we don’t know @TrendsinPharma. We want to understand whether potential #psychedelic actions in the gut may be relevant for therapeutic outcomes 🤨🍄👇🏼 https://t.co/U9ClDSN4kR

[Claire Foldi @ClaireFoldi]

Was a pleasure working with ⁦@KynaConn⁩ on this proposal in ⁦@IntJEatDisord⁩ to better understand and treat #compulsive exercise in #anorexia nervosa. Thanks to ⁦⁦@KaixinCHuang⁩ & @sashadmo⁩ for their valuable input👇🏼 https://t.co/g9LpmM8SAs

[Claire Foldi @ClaireFoldi]

Boom💥new preprint just dropped! #psychedelics activity-based #anorexia, reinforcement learning, behavioural pharmacology + cortical 5-HT1A & 5-HT2A transcription. Led by the inimitable @KynaConn & @LauraKMilton 💪🏼 @MonashBDI👇🏼 Check it out! 🍄🐁

[Kyna Conn @KynaConn]

Back to work Monday after a fantastic time at #BPA2023. Thanks for the opportunity to present amongst the highest ranked abstracts and to experience FNQ! Here is the #FoldiLab at the cutting edge of '(noo)tropics' chic 💅

[Kyna Conn @KynaConn]

@JKesby @ClaireFoldi @BurneTom Absolutely!

[Kyna Conn @KynaConn]

Delighted to see this study published with the old PhD supervisory team @JKesby and @BurneTom indicating that altering D1:D2 receptor signalling ratios improves amphetamine-induced learning impairments in mice, with implications for schizophrenia

https://t.co/p7INZLBhK3